HARVARD BIOSCIENCE INC 8-K

What Happened Harvard Bioscience, Inc. filed a Form 8-K on May 12, 2026 (Item 7.01) to disclose a corporate slide presentation used to update the investment community. The presentation, dated May 2026, is attached as Exhibit 99.1 and has been incorporated by reference. The filing is a Regulation FD disclosure intended to make the company’s investor materials broadly available.

Key Details

• 8-K filed on May 12, 2026 under Item 7.01 (Regulation FD Disclosure).
• Exhibit 99.1: Corporate slide presentation of Harvard Bioscience, dated May 2026.
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) included with the filing.
• Presentation is used at industry and investor conferences to provide updates and summaries of the business.

Why It Matters This filing gives investors access to Harvard Bioscience’s current investor presentation, which may contain strategic updates, product or pipeline highlights, or management messaging. The 8-K does not report earnings, financial results, or material transactions—it's a disclosure of investor materials under Regulation FD—so investors should review the attached slides for any new details but not assume new financial guidance unless explicitly stated in the presentation.